[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-338817-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-338817-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","overexpressing-lipid-raft-protein-stoml2-modulates-the-tumor-microenvironment-via-nf-b-signaling-in-colorectal-cancer","Overexpressing lipid raft protein STOML2 modulates the tumor microenvironment via NF-κB signaling in colorectal cancer","","Colorectal cancer (CRC) features a tumor inflammatory microenvironment in which angiogenesis and immunosuppression often occur together. The work identifies lipid raft protein STOML2 as upregulated in CRC, correlating with advanced stage and poor survival. Functionally, STOML2 is shown to drive inflammatory microenvironmental programs that simultaneously induce angiogenesis and promote immune escape in vitro and in vivo, and its overexpression improves response to anti-angiogenesis and immunotherapy. Mechanistically, STOML2 activates NF-κB signaling through TRADD binding, increasing CCND1, VEGF, and PD-L1, while NF-κB inhibition reverses proliferation and angiogenesis. Clinically, STOML2 expression associates with Ki67, CD31, VEGFC, and CD8+ T cell PD-1.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/overexpressing-lipid-raft-protein-stoml2-modulates-the-tumor-microenvironment-via-nf-b-signaling-in-colorectal-cancer/338817/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/overexpressing-lipid-raft-protein-stoml2-modulates-the-tumor-microenvironment-via-nf-b-signaling-in-colorectal-cancer/338817.png","ImageObject",300,407,{"name":42,"@type":43},"Jiven","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main role of STOML2 in colorectal cancer tumor microenvironment?","Question",{"text":63,"@type":64},"STOML2 is essential for the CRC tumor inflammatory microenvironment, driving angiogenesis and facilitating tumor immune escape simultaneously in vitro and in vivo.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does STOML2 activate the signaling pathway involved in CRC progression?",{"text":68,"@type":64},"STOML2 regulates CRC proliferation, angiogenesis, and immune escape by activating NF-κB signaling through binding to the TRADD protein, leading to increased CCND1, VEGF, and PD-L1.",{"name":70,"@type":61,"acceptedAnswer":71},"Does blocking NF-κB affect STOML2-driven effects?",{"text":72,"@type":64},"Yes. Treatment with an NF-κB inhibitor dramatically reverses STOML2-associated abilities for proliferation and angiogenesis.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},338817,1790515544,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":109,"preview_page_count":33,"preview_urls":145},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","Cellular and Molecular Life Sciences (2024) 81:39  \n[https://doi.org/10.1007/s00018-023-05105-y](https://doi.org/10.1007/s00018-023-05105-y) Cellular and Molecular Life Sciences  \nOverexpressing lipid raft protein STOML2 modulates the tumor microenvironment via NF‑κB signaling in colorectal cancer  \nHui Gong1 · Shaojing Chen2 · Shuguang Liu3 · Qianying Hu2 · Yixuan Li2 · Yifan Li1 · Guiqiu Li1 · Kaimeng Huang4,5 · Riqing Li6 · Lishan Fang2  \nReceived: 29 August 2023 / Revised: 12 November 2023 / Accepted: 22 December 2023 © The Author(s) 2024  \nAbstract  \nColorectal cancer (CRC) is characterized by a complex tumor inflammatory microenvironment, while angiogenesis and immunosuppression frequently occur concomitantly. However, the exact mechanism that controls angiogenesis and immunosuppression in CRC microenvironment remains unclear. Herein, we found that expression levels of lipid raft protein STOML2 were increased in CRC and were associated with advanced disease stage and poor survival outcomes. Intriguingly, we revealed that STOML2 is essential for CRC tumor inflammatory microenvironment, which induces angiogenesis and facilitates tumor immune escape simultaneously both in vitro and in vivo. Moreover, tumors with STOML2 overexpression showed effective response to anti-angiogenesis treatment and immunotherapy in vivo. Mechanistically, STOML2 regulates CRC proliferation, angiogenesis, and immune escape through activated NF-κB signaling pathway via binding to TRADD protein, resulting in upregulation of CCND1, VEGF, and PD-L1. Furthermore, treatment with NF-κB inhibitor dramatically reversed the ability of proliferation and angiogenesis. Clinically, we also observed a strong positive correlation between STOML2 expression and Ki67, CD31, VEGFC and PD-1 of CD8+T cell expression. Taken together, our results provided novel insights into the role of STOML2 in CRC inflammatory microenvironment, which may present a therapeutic opportunity for CRC.  \nKeywords STOML2 · Tumor microenvironment · Angiogenesis · Lipid rafts · NF-κB · Colorectal cancer  \nHui Gong, Shaojing Chen, Shuguang Liu and Qianying Hu contributed equally to this work and share first authorship.  \n* Guiqiu Li[lgq7566@126.com](lgq7566@126.com)  \n* Kaimeng Huang [Kaimeng_huang@dfci.Harvard.edu](Kaimeng_huang@dfci.Harvard.edu)  \n* Riqing Li[liriqing246@163.com](liriqing246@163.com)  \n* Lishan Fang [fanglsh5@mail.sysu.edu.cn](fanglsh5@mail.sysu.edu.cn)  \n1 Clinical Laboratory, Huazhong University of Science and Technology Union Shenzhen Hospital/Shenzhen Nanshan People’s Hospital/The 6th Affiliated Hospital of Shenzhen University Medical School, Shenzhen 518052, Guangdong, China  \nIntroduction  \nColorectal cancer (CRC), one of the most common malignant tumors of the digestive system, has the third-highest incidence rate and the second-highest death rate. Despite the remarkable advances in therapeutic strategies, the 5-year  \n2 Medical Research Center, The Eighth Affiliated Hospital, Sun Yat-Sun University, Shenzhen 518033, China  \n3 Department of Pathology, The Eighth Affiliated Hospital, Sun Yat-Sun University, Shenzhen 518033, China  \n4 Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA  \n5 CAS Key Laboratory of Regenerative Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China  \n6 Shenzhen Agricultural Technology Promotion Center, Shenzhen 518005, China  \noverall survival rate with CRC remains poor [1] . Although, anti-angiogenesis (Bevacizumab) and immunotherapy are used as the first-line treatment and achieve great success ina subset of advanced metastatic CRC patients, it is still of limited efficacy in the majority of cancers [2–5] . Thus, it is crucial to understand the underlying mechanism in order to exploit novel biomarkers and guide CRC therapeutic strategies.  \nThe tumor microenvironment plays an important","cbCaies8Oocflht8","https://ap.wps.com/l/cbCaies8Oocflht8","pdf",13210307,16,"English","# Abstract\n## Background and problem\n## Key findings on STOML2 expression and clinical relevance\n## Mechanistic pathway and functional outcomes\n## Therapeutic implications and clinical correlations\n# Introduction\n## CRC treatment challenges and need for mechanisms\n## Tumor microenvironment and concurrence of angiogenesis/immunosuppression\n## Lipid rafts and rationale for STOML2 in CRC","[{\"question\":\"What is the main role of STOML2 in colorectal cancer tumor microenvironment?\",\"answer\":\"STOML2 is essential for the CRC tumor inflammatory microenvironment, driving angiogenesis and facilitating tumor immune escape simultaneously in vitro and in vivo.\"},{\"question\":\"How does STOML2 activate the signaling pathway involved in CRC progression?\",\"answer\":\"STOML2 regulates CRC proliferation, angiogenesis, and immune escape by activating NF-κB signaling through binding to the TRADD protein, leading to increased CCND1, VEGF, and PD-L1.\"},{\"question\":\"Does blocking NF-κB affect STOML2-driven effects?\",\"answer\":\"Yes. Treatment with an NF-κB inhibitor dramatically reverses STOML2-associated abilities for proliferation and angiogenesis.\"}]","Overexpressing lipid raft protein STOML2 modulates the tumor microenvironment via NF-κB signaling in colorectal cancer | PDF",1790025907,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/88b165d655a052c6784a6f03c4d53e07.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b9f389d29b32bf183756dd534c350a70.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8d9070c2c392f83b22e84d7d7b1bae41.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4f571736be67ce8d33510223c402b07b.webp",980,1301]